Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

205.48 -1.84 (-0.89%)

Streaming Delayed Price Updated: 2:05 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

July 16, 2025

Via Benzinga

Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday ↗

July 16, 2025

Via Benzinga

What's going on in today's session: S&P500 movers ↗

July 16, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Johnson & Johnson Reportedly Halves Its Forecast Of US Tariff Impact To $200M, Sparks Retail Chatter ↗

July 16, 2025

Via Stocktwits

What's Next: Johnson & Johnson's Earnings Preview ↗

July 15, 2025

Via Benzinga

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript ↗

July 16, 2025

Via The Motley Fool

Topics Earnings

Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report ↗

July 16, 2025

The company also easily beat second-quarter adjusted earnings and sales forecasts.

Via Investor's Business Daily

Topics Stocks

Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance ↗

July 16, 2025

Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara declines.

Via Benzinga

Johnson & Johnson (NYSE:JNJ) Reports Bullish Q2, Full-Year Sales Guidance is Optimistic

July 16, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 5.8% year on year to $23.74 billion. The company’s full-year revenue...

Via StockStory

Johnson & Johnson Outperforms Q2 Expectations; Provides Positive Outlook ↗

July 16, 2025

Johnson & Johnson surpassed expectations in Q2 2025 with a notable increase in earnings per share and revenue.

Via Talk Markets

Dow Futures Edge Up Even As Investors Maintain Caution: ASML, UAL, JNJ, BAC, GS Among Stocks To Watch ↗

July 16, 2025

Via Stocktwits

Topics Stocks

3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever ↗

July 16, 2025

Via The Motley Fool

Topics Stocks

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

July 16, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook

July 16, 2025

From Johnson & Johnson

Via Business Wire

Earnings Scheduled For July 16, 2025 ↗

July 16, 2025

Via Benzinga

10 Dividend Stocks to Double Up On Right Now ↗

July 15, 2025

Via The Motley Fool

Topics Artificial Intelligence

Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. ↗

July 15, 2025

Via The Motley Fool

Topics Retirement

Should You Buy Johnson & Johnson Stock Before July 16th? ↗

July 15, 2025

Via The Motley Fool

Topics Government World Trade

These 3 Undervalued Stocks Could Surge as Value Rotation Nears ↗

July 14, 2025

A rotation back into value stocks may be imminent in today's market, giving investors a chance to expose themselves into a catch up play.

Via MarketBeat

Topics ETFs Economy

Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit ↗

July 14, 2025

Via The Motley Fool

Topics Regulatory Compliance

Kenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO Role ↗

July 14, 2025

Perry has previously worked with Circana, Google, and was with Procter and Gamble for 23 years.

Via Stocktwits

Topics Government Stocks

This Stock Has Increased 4,720%: Here's Why It's Still a Buy ↗

July 13, 2025

Via The Motley Fool

5 of the Best Stocks to Buy in July ↗

July 11, 2025

These stocks are ready to pop higher.

Via The Motley Fool

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.

Via Benzinga

Topics Government World Trade

The Best High Yield Medical Device Stock to Invest $1,000 in Right Now ↗

July 11, 2025

Via The Motley Fool

What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill ↗

July 11, 2025

A steady dose of quality companies will keep your portfolio growing big and strong.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

July 11, 2025

Via Benzinga

2 Dividend Stocks to Double Up on Right Now ↗

July 11, 2025

Via The Motley Fool

Forecasting The Future: 8 Analyst Projections For Johnson & Johnson ↗

July 10, 2025

Via Benzinga

Option Wheel Strategy: How to Earn Monthly Income Trading Options

July 10, 2025

The search for consistent, predictable income is a constant for investors in both bull and bear markets. While traditional dividend stocks and bonds are reliable tools, a lesser-known but increasingly...

Via MarketMinute

Topics Bonds Retirement

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

All News about Johnson & Johnson

Starting at $3.75/week.

Subscribe Today